225 related articles for article (PubMed ID: 21703428)
1. Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
Cisowski J; O'Callaghan K; Kuliopulos A; Yang J; Nguyen N; Deng Q; Yang E; Fogel M; Tressel S; Foley C; Agarwal A; Hunt SW; McMurry T; Brinckerhoff L; Covic L
Am J Pathol; 2011 Jul; 179(1):513-23. PubMed ID: 21703428
[TBL] [Abstract][Full Text] [Related]
2. Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis.
Yang E; Boire A; Agarwal A; Nguyen N; O'Callaghan K; Tu P; Kuliopulos A; Covic L
Cancer Res; 2009 Aug; 69(15):6223-31. PubMed ID: 19622769
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin is involved in the activated internalization and degradation of protease-activated receptor 1.
Wang YJ; Guo XL; Li SA; Zhao YQ; Liu ZC; Lee WH; Xiang Y; Zhang Y
Biochim Biophys Acta; 2014 Jul; 1843(7):1393-401. PubMed ID: 24732013
[TBL] [Abstract][Full Text] [Related]
4. Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach.
Covic L; Kuliopulos A
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065181
[TBL] [Abstract][Full Text] [Related]
5. Characterization and functional activity of thrombin receptors in the human lens.
James C; Collison DJ; Duncan G
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):925-32. PubMed ID: 15728549
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
7. Distinct activity of peptide mimetic intracellular ligands (pepducins) for proteinase-activated receptor-1 in multiple cells/tissues.
Kubo S; Ishiki T; Doe I; Sekiguchi F; Nishikawa H; Kawai K; Matsui H; Kawabata A
Ann N Y Acad Sci; 2006 Dec; 1091():445-59. PubMed ID: 17341635
[TBL] [Abstract][Full Text] [Related]
8. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
[TBL] [Abstract][Full Text] [Related]
9. Targeting A549 lung adenocarcinoma cell growth and invasion with protease‑activated receptor‑1 siRNA.
Wu Z; Zeng Y; Zhong M; Wang B
Mol Med Rep; 2014 May; 9(5):1787-93. PubMed ID: 24604247
[TBL] [Abstract][Full Text] [Related]
10. The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion.
Fujimoto D; Hirono Y; Goi T; Katayama K; Matsukawa S; Yamaguchi A
BMC Cancer; 2010 Aug; 10():443. PubMed ID: 20723226
[TBL] [Abstract][Full Text] [Related]
11. Altered protease-activated receptor-1 expression and signaling in a malignant pleural mesothelioma cell line, NCI-H28, with homozygous deletion of the β-catenin gene.
Fazzini A; D'Antongiovanni V; Giusti L; Da Valle Y; Ciregia F; Piano I; Caputo A; D'Ursi AM; Gargini C; Lucacchini A; Mazzoni MR
PLoS One; 2014; 9(11):e111550. PubMed ID: 25364818
[TBL] [Abstract][Full Text] [Related]
12. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins.
Sevigny LM; Zhang P; Bohm A; Lazarides K; Perides G; Covic L; Kuliopulos A
Proc Natl Acad Sci U S A; 2011 May; 108(20):8491-6. PubMed ID: 21536878
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
14. Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics.
Zhang P; Leger AJ; Baleja JD; Rana R; Corlin T; Nguyen N; Koukos G; Bohm A; Covic L; Kuliopulos A
J Biol Chem; 2015 Jun; 290(25):15785-15798. PubMed ID: 25934391
[TBL] [Abstract][Full Text] [Related]
15. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
16. Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation.
Wang H; Moreau F; Hirota CL; MacNaughton WK
FASEB J; 2010 Jun; 24(6):1971-80. PubMed ID: 20065107
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells.
Banfi C; Brioschi M; Barcella S; Pignieri A; Parolari A; Biglioli P; Tremoli E; Mussoni L
J Thromb Haemost; 2007 Dec; 5(12):2437-44. PubMed ID: 17848177
[TBL] [Abstract][Full Text] [Related]
18. Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer.
Agarwal A; Covic L; Sevigny LM; Kaneider NC; Lazarides K; Azabdaftari G; Sharifi S; Kuliopulos A
Mol Cancer Ther; 2008 Sep; 7(9):2746-57. PubMed ID: 18790755
[TBL] [Abstract][Full Text] [Related]
19. Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cells.
Rohani MG; Beyer RP; Hacker BM; Dommisch H; Dale BA; Chung WO
Innate Immun; 2010 Apr; 16(2):104-14. PubMed ID: 19567485
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole prevents triple-negative breast-cancer progression.
Spano D; Marshall JC; Marino N; De Martino D; Romano A; Scoppettuolo MN; Bello AM; Di Dato V; Navas L; De Vita G; Medaglia C; Steeg PS; Zollo M
Clin Exp Metastasis; 2013 Jan; 30(1):47-68. PubMed ID: 22760522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
